Recursion Pharmaceuticals Inc vs Victoria's Secret & Co — how do they compare? Recursion Pharmaceuticals Inc trades at $3.37 (market cap $1.81B), while Victoria's Secret & Co trades at $94.55 (market cap $7.48B). The key difference: Victoria's Secret & Co is far larger — about 4.1× Recursion Pharmaceuticals Inc's market cap, and Victoria's Secret & Co is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| RXRX | VSXY | |
|---|---|---|
Market Cap | $1.81B | $7.48B |
Sector | Health | Consumer Cyclical |
52-Week High | $6.79 | $99.97 |
52-Week Low | $2.84 | $21.34 |
Enterprise Value | $1.33B | $10.13B |
Trailing returns across standard periods
Latest headlines on both assets
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →